⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL372610 | 1.00 | — | — | |
| SCHEMBL135308 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL842523 | 0.97 | — | — | |
| Water SCHEMBL28328236 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL135306 | 0.97 | — | — | |
| Bromide SCHEMBL5401279 | 0.97 | — | — | |
| Bromide SCHEMBL5401276 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL135307 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL5202071 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL2255171 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673426-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | Locus Solutions IPCO, LLC (US) | 2026-01-07 | — | — | EP | claimed |
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-20240301322-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO LLC (US) | 2024-09-12 | — | — | US | claimed |
| WO-2024182125-A1 | FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-09-06 | — | — | WO | claimed |
| CN-117924684-A | Preparation method of amino-terminated polyether | 山东隆华新材料股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117883305-A | N-long-chain acyl alanine monoester compound and preparation method thereof | 南京华狮新材料有限公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2024065907-A1 | PENTACYCLIC TRITERPENE SAPONIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 苏州大学 | 2024-04-04 | — | — | WO | claimed |
| CN-117776952-A | Cyclic preparation method of vitamin B6 intermediate | 杭州鑫富科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-116836219-A | Synthesis of novel corosolic acid derivatives and their use in insulin resistance and anti-inflammatory therapy | 苏州大学 | 2023-10-03 | — | — | CN | claimed |
| CN-116769762-A | Immobilized aminopeptidase and preparation method and application thereof | 上海百福安生物科技有限公司 | 2023-09-19 | — | — | CN | claimed |
| WO-2001036516-A1 | BIODEGRADABLE AND THERMOSENSITIVE POLYPHOSPHAZENES AND THEIR PREPARATION METHOD | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-05-25 | — | — | WO | claimed |
| EP-1007026-A1 | INTEGRIN ANTAGONISTS | Merck & Co., Inc. (US) | 2000-06-14 | — | — | EP | claimed |
| US-6015774-A | Pyrazin-2-one derivatives, their use, and intermediates for their production | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-01-18 | — | — | US | claimed |
| CN-1237960-A | N (aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds | YEELAN PHARMACEUTICAL CORP (US) | 1999-12-08 | — | — | CN | claimed |
| WO-1998031359-A1 | INTEGRIN ANTAGONISTS | MERCK & CO., INC. (US) | 1998-07-23 | — | — | WO | claimed |
| US-5430026-A | Anticancer agents, viricides | ELI LILLY AND COMPANY (US) | 1995-07-04 | — | — | US | claimed |
| CN-1084177-A | 2 of the antiviral and antitumour activity of tool '-deoxidation-2 ', 2 '-difluoro (4-substituted pyrimidines) nucleosides and intermediate | LILLY CO ELI (US) | 1994-03-23 | — | — | CN | claimed |
| EP-0576230-A1 | 2'-deoxy-2', 2'-difluoro(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates | ELI LILLY AND COMPANY (US) | 1993-12-29 | — | — | EP | claimed |
| EP-0050856-B1 | NEW PEPTIDE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING IT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-12-27 | — | — | EP | claimed |
| EP-0050856-A2 | New peptide, process for its preparation and pharmaceutical composition containing it | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-05-05 | — | — | EP | claimed |